• Marlène Wiart, Nathalie Davoust, Jean-Baptiste Pialat, Virginie Desestret, Samir Moucharrafie, Samir Moucharaffie, Tae-Hee Cho, Mireille Mutin, Jean-Baptiste Langlois, Olivier Beuf, Jérôme Honnorat, Norbert Nighoghossian, and Yves Berthezène.
• Université de Lyon, Lyon, F-69003, France. wiart@creatis.insa-lyon.fr
• Stroke. 2007 Jan 1;38(1):131-7.

Background And PurposeA growing body of evidence suggests that inflammatory processes are involved in the pathophysiology of stroke. Phagocyte cells, involving resident microglia and infiltrating macrophages, secrete both protective and toxic molecules and thus represent a potential therapeutic target. The aim of the present study was to monitor phagocytic activity after focal cerebral ischemia in mice.MethodsUltrasmall superparamagnetic particles of iron oxide (USPIO) were intravenously injected after permanent middle cerebral artery occlusion and monitored by high resolution MRI for 72 hours.ResultsWe here present the first MRI data showing in vivo phagocyte-labeling obtained in mice with focal cerebral ischemia. USPIO-enhanced MRI kinetic analysis disclosed an inflammatory response surrounding the ischemic lesion and in the contralateral hemisphere via the corpus callosum. The imaging data collected during the first 36 hours postinjury suggested a spread of USPIO-related signal from ipsi- to contralateral hemisphere. Imaging data correlated with histochemical analysis showing inflammation remote from the lesion and ingestion of nanoparticles by microglia/macrophages.ConclusionsThe present study shows that MR-tracking of phagocyte cells is feasible in mice, which may have critical therapeutic implications given the potential neurotoxicity of activated microglia/macrophages in central nervous system disorders.

35 keywords...

hide…